{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T06:57:59Z","timestamp":1790837879895,"version":"4.1.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T00:00:00Z","timestamp":1769385600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T00:00:00Z","timestamp":1769385600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Biomed Eng"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1007\/s10439-026-03978-1","type":"journal-article","created":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T15:52:41Z","timestamp":1769442761000},"page":"1334-1344","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Stacking Ensemble Machine Learning for Cardiac Safety Assessment Using hiPSC-CM MEA Data"],"prefix":"10.1007","volume":"54","author":[{"given":"Muhammad Adnan","family":"Pramudito","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunendah Nur","family":"Fuadah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoo Seok","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ki Moo","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,26]]},"reference":[{"key":"3978_CR1","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.vascn.2016.06.002","volume":"81","author":"T Colatsky","year":"2016","unstructured":"Colatsky, T., B. Fermini, G. Gintant, J. B. Pierson, P. Sager, Y. Sekino, D. G. Strauss, and N. Stockbridge. The Comprehensive in Vitro Proarrhythmia Assay (CiPA) initiative \u2014 Update on progress. J Pharmacol Toxicol Methods. 81:15\u201320, 2016. https:\/\/doi.org\/10.1016\/j.vascn.2016.06.002.","journal-title":"J Pharmacol Toxicol Methods"},{"key":"3978_CR2","doi-asserted-by":"publisher","unstructured":"Gintant, G. A. Preclinical Torsades-de-Pointes Screens: Advantages and limitations of surrogate and direct approaches in evaluating proarrhythmic risk. , 2008. https:\/\/doi.org\/10.1016\/j.pharmthera.2008.04.010","DOI":"10.1016\/j.pharmthera.2008.04.010"},{"key":"3978_CR3","unstructured":"Ema, and Step. ICH guideline E14\/S7B: clinical and Nonclinical Evaluation of QT\/QTc Interval Prolongation and Proarrhythmic Potential-questions and answers"},{"key":"3978_CR4","doi-asserted-by":"crossref","unstructured":"Shah, R. R. Drugs, QTc Interval Prolongation and Final ICH E14 Guideline An Important Milestone with Challenges Ahead. 2005.","DOI":"10.2165\/00002018-200528110-00003"},{"key":"3978_CR5","doi-asserted-by":"publisher","unstructured":"Sager, P. T., G. Gintant, J. R. Turner, S. Pettit, and N. Stockbridge. Rechanneling the cardiac proarrhythmia safety paradigm: A meeting report from the Cardiac Safety Research Consortium. , 2014. https:\/\/doi.org\/10.1016\/j.ahj.2013.11.004","DOI":"10.1016\/j.ahj.2013.11.004"},{"key":"3978_CR6","doi-asserted-by":"publisher","unstructured":"Fermini, B., J. C. Hancox, N. Abi-Gerges, M. Bridgland-Taylor, K. W. Chaudhary, T. Colatsky, K. Correll, W. Crumb, B. Damiano, G. Erdemli, G. Gintant, J. Imredy, J. Koerner, J. Kramer, P. Levesque, Z. Li, A. Lindqvist, C. A. Obejero-Paz, D. Rampe, K. Sawada, D. G. Strauss, and J. I. Vandenberg. A new perspective in the field of cardiac safety testing through the comprehensive in vitro proarrhythmia assay paradigm. , 2016. https:\/\/doi.org\/10.1177\/1087057115594589","DOI":"10.1177\/1087057115594589"},{"key":"3978_CR7","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1177\/2168479018795117","volume":"53","author":"DG Strauss","year":"2019","unstructured":"Strauss, D. G., G. Gintant, Z. Li, W. Wu, K. Blinova, J. Vicente, J. R. Turner, and P. T. Sager. Comprehensive In Vitro Proarrhythmia Assay (CiPA) Update from a Cardiac Safety Research Consortium \/ Health and Environmental Sciences Institute \/ FDA Meeting. Ther Innov Regul Sci. 53:519\u2013525, 2019. https:\/\/doi.org\/10.1177\/2168479018795117.","journal-title":"Ther Innov Regul Sci"},{"key":"3978_CR8","doi-asserted-by":"publisher","unstructured":"Li, Z., S. Dutta, J. Sheng, P. N. Tran, W. Wu, K. Chang, T. Mdluli, D. G. Strauss, and T. Colatsky. Improving the in silico assessment of proarrhythmia risk by combining hERG (Human Ether-\u00e0-go-go-Related Gene) channel-drug binding kinetics and multichannel pharmacology. Circ Arrhythm Electrophysiol 10:, 2017. https:\/\/doi.org\/10.1161\/CIRCEP.116.004628","DOI":"10.1161\/CIRCEP.116.004628"},{"key":"3978_CR9","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.vascn.2016.12.003","volume":"84","author":"H Ando","year":"2017","unstructured":"Ando, H., et al. A new paradigm for drug-induced torsadogenic risk assessment using human iPS cell-derived cardiomyocytes. J Pharmacol Toxicol Methods. 84:111\u2013127, 2017. https:\/\/doi.org\/10.1016\/j.vascn.2016.12.003.","journal-title":"J Pharmacol Toxicol Methods"},{"key":"3978_CR10","doi-asserted-by":"publisher","first-page":"3582","DOI":"10.1016\/j.celrep.2018.08.079","volume":"24","author":"K Blinova","year":"2018","unstructured":"Blinova, K., Q. Dang, D. Millard, G. Smith, J. Pierson, L. Guo, M. Brock, H. R. Lu, U. Kraushaar, H. Zeng, H. Shi, X. Zhang, K. Sawada, T. Osada, Y. Kanda, Y. Sekino, L. Pang, T. K. Feaster, R. Kettenhofen, N. Stockbridge, D. G. Strauss, and G. Gintant. International Multisite Study of Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes for Drug Proarrhythmic Potential Assessment. Cell Rep. 24:3582\u20133592, 2018. https:\/\/doi.org\/10.1016\/j.celrep.2018.08.079.","journal-title":"Cell Rep"},{"key":"3978_CR11","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1093\/toxsci\/kfu084","volume":"140","author":"M Clements","year":"2014","unstructured":"Clements, M., and N. Thomas. High-throughput multi-parameter profiling of electrophysiological drug effects in human embryonic stem cell derived cardiomyocytes using multi-electrode arrays. Toxicol Sci. 140:445\u2013461, 2014. https:\/\/doi.org\/10.1093\/toxsci\/kfu084.","journal-title":"Toxicol Sci"},{"key":"3978_CR12","doi-asserted-by":"crossref","unstructured":"Blinova, K., J. Stohlman, J. Vicente, D. Chan, L. Johannesen, M. P. Hortigon-Vinagre, V. Zamora, G. Smith, W. J. Crumb, L. Pang, B. Lyn-Cook, J. Ross, M. Brock, S. Chvatal, D. Millard, L. Galeotti, N. Stockbridge, and D. G. Strauss. Comprehensive Translational Assessment of Human Induced Pluripotent Stem Cell Derived Cardiomyocytes for Evaluating Drug-Induced Arrhythmias Downloaded from. 2016.at <http:\/\/toxsci.oxfordjournals.org\/>","DOI":"10.1093\/toxsci\/kfw200"},{"key":"3978_CR13","doi-asserted-by":"publisher","unstructured":"Golgooni, Z., S. Mirsadeghi, M. S. Baghshah, P. Ataee, H. Baharvand, S. Pahlavan, and H. R. Rabiee. Deep learning-based proarrhythmia analysis using field potentials recorded from human pluripotent stem cells derived cardiomyocytes. IEEE J Transl Eng Health Med 7:, 2019. https:\/\/doi.org\/10.1109\/JTEHM.2019.2907945","DOI":"10.1109\/JTEHM.2019.2907945"},{"key":"3978_CR14","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.stem.2022.12.002","volume":"30","author":"R Serrano","year":"2023","unstructured":"Serrano, R., D. A. M. Feyen, A. A. N. Bruyneel, A. P. Hnatiuk, M. M. Vu, P. L. Amatya, I. Perea-Gil, M. Prado, T. Seeger, J. C. Wu, I. Karakikes, and M. Mercola. A deep learning platform to assess drug proarrhythmia risk. Cell Stem Cell. 30:86-95.e4, 2023. https:\/\/doi.org\/10.1016\/j.stem.2022.12.002.","journal-title":"Cell Stem Cell"},{"key":"3978_CR15","doi-asserted-by":"publisher","unstructured":"Yang, X., A. J. S. Ribeiro, L. Pang, and D. G. Strauss. Use of Human iPSC-CMs in Nonclinical Regulatory Studies for Cardiac Safety Assessment. , 2022. https:\/\/doi.org\/10.1093\/toxsci\/kfac095","DOI":"10.1093\/toxsci\/kfac095"},{"key":"3978_CR16","doi-asserted-by":"publisher","unstructured":"Pan, D., B. Li, and S. Wang. Establishment and validation of a torsade de pointes prediction model based on human iPSC-derived cardiomyocytes. Exp Ther Med 25:, 2022. https:\/\/doi.org\/10.3892\/etm.2022.11760","DOI":"10.3892\/etm.2022.11760"},{"key":"3978_CR17","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1089\/adt.2014.592","volume":"12","author":"O Sirenko","year":"2014","unstructured":"Sirenko, O., J. Hesley, I. Rusyn, and E. F. Cromwell. High-content high-throughput assays for characterizing the viability and morphology of human iPSC-derived neuronal cultures. Assay Drug Dev Technol. 12:536\u2013547, 2014. https:\/\/doi.org\/10.1089\/adt.2014.592.","journal-title":"Assay Drug Dev Technol"},{"key":"3978_CR18","doi-asserted-by":"publisher","unstructured":"Ma, J., L. Guo, S. J. Fiene, B. D. Anson, J. A. Thomson, T. J. Kamp, K. L. Kolaja, B. J. Swanson, and C. T. January. High purity human-induced pluripotent stem cell-derived cardiomyocytes: Electrophysiological properties of action potentials and ionic currents. Am J Physiol Heart Circ Physiol 301:, 2011. https:\/\/doi.org\/10.1152\/ajpheart.00694.2011","DOI":"10.1152\/ajpheart.00694.2011"},{"key":"3978_CR19","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1016\/j.taap.2013.09.017","volume":"273","author":"O Sirenko","year":"2013","unstructured":"Sirenko, O., E. F. Cromwell, C. Crittenden, J. A. Wignall, F. A. Wright, and I. Rusyn. Assessment of beating parameters in human induced pluripotent stem cells enables quantitative in vitro screening for cardiotoxicity. Toxicol Appl Pharmacol. 273:500\u2013507, 2013. https:\/\/doi.org\/10.1016\/j.taap.2013.09.017.","journal-title":"Toxicol Appl Pharmacol"},{"key":"3978_CR20","doi-asserted-by":"publisher","unstructured":"Park, Y. G., N. K. Park, Y. Lee, M. A. Pramudito, Y. J. Son, H. Park, A. I. Qauli, S. W. Choi, K. Ban, J. Il Choi, S. J. Park, H. J. Park, K. M. Lim, S. K. Koo, J. H. Kim, and S. H. Moon. A machine learning platform for genotype-specific cardiotoxicity risk prediction using patient-derived iPSC-CMs. J Adv Res , 2025. https:\/\/doi.org\/10.1016\/j.jare.2025.07.030","DOI":"10.1016\/j.jare.2025.07.030"},{"key":"3978_CR21","doi-asserted-by":"publisher","unstructured":"Yoo, Y., A. Marcellinus, D. U. Jeong, K. S. Kim, and K. M. Lim. Assessment of Drug Proarrhythmicity Using Artificial Neural Networks With in silico Deterministic Model Outputs. Front Physiol 12:, 2021. https:\/\/doi.org\/10.3389\/fphys.2021.761691","DOI":"10.3389\/fphys.2021.761691"},{"key":"3978_CR22","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1002\/cpt.1184","volume":"105","author":"Z Li","year":"2019","unstructured":"Li, Z., B. J. Ridder, X. Han, W. W. Wu, J. Sheng, P. N. Tran, M. Wu, A. Randolph, R. H. Johnstone, G. R. Mirams, Y. Kuryshev, J. Kramer, C. Wu, W. J. Crumb, and D. G. Strauss. Assessment of an In Silico Mechanistic Model for Proarrhythmia Risk Prediction Under the CiPA Initiative. Clin Pharmacol Ther. 105:466\u2013475, 2019. https:\/\/doi.org\/10.1002\/cpt.1184.","journal-title":"Clin Pharmacol Ther"},{"key":"3978_CR23","doi-asserted-by":"publisher","unstructured":"Jeong, D. U., T. Nurul Qashri Mahardika, A. Marcellinus, and K. M. Lim. qInward variability-based in-silico proarrhythmic risk assessment of drugs using deep learning model. Front Physiol 13:, 2022. https:\/\/doi.org\/10.3389\/fphys.2022.1080190","DOI":"10.3389\/fphys.2022.1080190"},{"key":"3978_CR24","doi-asserted-by":"publisher","first-page":"24045","DOI":"10.1038\/s41598-024-71169-w","volume":"14","author":"MA Pramudito","year":"2024","unstructured":"Pramudito, M. A., Y. N. Fuadah, A. I. Qauli, A. Marcellinus, and K. M. Lim. Explainable artificial intelligence (XAI) to find optimal in-silico biomarkers for cardiac drug toxicity evaluation. Sci Rep. 14:24045, 2024. https:\/\/doi.org\/10.1038\/s41598-024-71169-w.","journal-title":"Sci Rep"},{"key":"3978_CR25","doi-asserted-by":"publisher","unstructured":"Fuadah, Y. N., A. I. Qauli, A. Marcellinus, M. A. Pramudito, and K. M. Lim. Machine learning approach to evaluate TdP risk of drugs using cardiac electrophysiological model including inter-individual variability. Front Physiol 14:, 2023. https:\/\/doi.org\/10.3389\/fphys.2023.1266084","DOI":"10.3389\/fphys.2023.1266084"},{"key":"3978_CR26","doi-asserted-by":"publisher","DOI":"10.1002\/psp4.13229","author":"YN Fuadah","year":"2024","unstructured":"Fuadah, Y. N., A. I. Qauli, M. A. Pramudito, A. Marcellinus, U. L. Hanum, and K. M. Lim. A stacking ensemble machine learning model for evaluating cardiac toxicity of drugs based on in silico biomarkers. CPT Pharmacometrics Syst Pharmacol. 2024. https:\/\/doi.org\/10.1002\/psp4.13229.","journal-title":"CPT Pharmacometrics Syst Pharmacol"},{"key":"3978_CR27","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1080\/1206212X.2021.1974663","volume":"44","author":"DM Belete","year":"2022","unstructured":"Belete, D. M., and M. D. Huchaiah. Grid search in hyperparameter optimization of machine learning models for prediction of HIV\/AIDS test results. International Journal of Computers and Applications. 44:875\u2013886, 2022. https:\/\/doi.org\/10.1080\/1206212X.2021.1974663.","journal-title":"International Journal of Computers and Applications"},{"key":"3978_CR28","doi-asserted-by":"publisher","unstructured":"Fuadah, Y. N., M. A. Pramudito, and K. M. Lim. An Optimal Approach for Heart Sound Classification Using Grid Search in Hyperparameter Optimization of Machine Learning. Bioengineering 10:, 2023. https:\/\/doi.org\/10.3390\/bioengineering10010045","DOI":"10.3390\/bioengineering10010045"},{"key":"3978_CR29","doi-asserted-by":"publisher","first-page":"12169","DOI":"10.1007\/s10639-023-11682-z","volume":"28","author":"JA Talam\u00e1s-Carvajal","year":"2023","unstructured":"Talam\u00e1s-Carvajal, J. A., and H. G. Ceballos. A stacking ensemble machine learning method for early identification of students at risk of dropout. Educ Inf Technol (Dordr). 28:12169\u201312189, 2023. https:\/\/doi.org\/10.1007\/s10639-023-11682-z.","journal-title":"Educ Inf Technol (Dordr)"},{"key":"3978_CR30","doi-asserted-by":"publisher","unstructured":"Kim, K., and J. Jeong. Multi-layer Stacking Ensemble for Fault Detection Classification in Hydraulic System. , 2022. https:\/\/doi.org\/10.1109\/CSCC55931.2022.00066","DOI":"10.1109\/CSCC55931.2022.00066"},{"key":"3978_CR31","doi-asserted-by":"publisher","unstructured":"Ghasemieh, A., A. Lloyed, P. Bahrami, P. Vajar, and R. Kashef. A novel machine learning model with Stacking Ensemble Learner for predicting emergency readmission of heart-disease patients. Decision Analytics Journal 7:, 2023. https:\/\/doi.org\/10.1016\/j.dajour.2023.100242","DOI":"10.1016\/j.dajour.2023.100242"},{"key":"3978_CR32","doi-asserted-by":"publisher","unstructured":"Jeong, D. U., R. Z. Danadibrata, A. Marcellinus, and K. M. Lim. Validation of in silico biomarkers for drug screening through ordinal logistic regression. Front Physiol 13:, 2022. https:\/\/doi.org\/10.3389\/fphys.2022.1009647","DOI":"10.3389\/fphys.2022.1009647"},{"key":"3978_CR33","doi-asserted-by":"publisher","unstructured":"Qauli, A. I., N. Q. M. T, U. L. Hanum, F. J. Vanheusden, and K. M. Lim. Elevating performance and interpretability of in silico classifiers for drug proarrhythmia risk evaluations using multi-biomarker approach with ranking algorithm. Comput Methods Programs Biomed 261:, 2025. https:\/\/doi.org\/10.1016\/j.cmpb.2025.108609","DOI":"10.1016\/j.cmpb.2025.108609"}],"container-title":["Annals of Biomedical Engineering"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10439-026-03978-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10439-026-03978-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10439-026-03978-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T21:27:37Z","timestamp":1776547657000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10439-026-03978-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,26]]},"references-count":33,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["3978"],"URL":"https:\/\/doi.org\/10.1007\/s10439-026-03978-1","relation":{},"ISSN":["0090-6964","1573-9686"],"issn-type":[{"value":"0090-6964","type":"print"},{"value":"1573-9686","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,26]]},"assertion":[{"value":"23 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ki Moo Lim is currently employed by Meta Heart Inc.All other authors declare that they have no commercial or financial relationships that could be interpreted as a potential conflict of interest in relation to this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of Interest"}},{"value":"Not applicable. This study used publicly available in vitro experimental data from hiPSC-CM MEA assays with no human participants or identifiable human data. Consequently, institutional review board approval and participant consent were not required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}}]}}